Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Trodelvy
Pharma
AZ, Daiichi kick off busy 2025 with FDA nod for their 2nd ADC
The TROP2 ADC also awaits an FDA decision in EGFR-mutated lung cancer and a key readout in first-line non-small cell lung cancer in 2025.
Angus Liu
Jan 17, 2025 9:14pm
AZ's Enhertu, Akeso's bispecifics win reimbursement in China
Dec 4, 2024 12:52pm
Kelun's Merck-partnered TROP2 ADC snags first nod in China
Nov 27, 2024 10:56am
Gilead's CAR-T sales stagnate as Trodelvy takes another write-off
Nov 7, 2024 11:16am
Gilead pulls Trodelvy in bladder cancer after trial flop
Oct 18, 2024 10:18am
Gilead unfolds Trodelvy triplet's first-line NSCLC data
Sep 9, 2024 1:45pm